| abstract |
Compounds of formula (I), wherein: R1 is optionally substituted heteroaromatic or aryl, and R2 is a radical of formula (II) or formula (III). The compounds are used for the manufacture of medicaments for treating diseases mediated by an antagonist of the áíâ3 receptor or áíâ5 receptor, and for the treatment of osteoporosis, angiogenesis, tumour growth, tumour metastasis, atherosclerosis, restenosis or rheumatoid arthritis. |